| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 269 | 2021 |
| Sustained T cell immunity, protection and boosting using extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, D Skelly, W Dejnirattisai, S Adele, ... | 21 | 2021 |
| mRNA vaccination drives differential mucosal neutralizing antibody profiles in naive and SARS-CoV-2 previously-infected individuals S Longet, A Hargreaves, S Healy, R Brown, HR Hornsby, N Meardon, ... Frontiers in immunology 13, 953949, 2022 | 16 | 2022 |
| Filovirus neutralising antibodies: mechanisms of action and therapeutic application A Hargreaves, C Brady, J Mellors, T Tipton, MW Carroll, S Longet Pathogens 10 (9), 1201, 2021 | 12 | 2021 |
